Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Top Medical Groups Issue New Guidelines for Treating Musculoskeletal Pain

D S Simon Media

The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) released a new clinical guideline recommending that physicians treat acute pain from non-low back musculoskeletal injuries with topical NSAIDs, as first-line therapy. Musculoskeletal injuries accounted for 65 MILLION health care visits in the US. Recently, Dr. Bob Arnot partnered with Salonpas and YourUpdateTV on a national satellite media tour to discuss this important topic. A video accompanying this announcement is available at: https://youtu.be/STZ5b3RHFJo The leading Medical groups, with more than 300,000 members, established new recommendations for treating acute pain from injuries such as sprains, strains and bruises based on a review of studies with more than 32,000 participants. They found that topical NSAIDs were most effective having the greatest net benefit for patients. This is a significant shift from using oral NSAIDs or Acetaminophen which are now listed as the second choice. In the guideline, the ACP and AAFP suggest against prescribing opioids for patients with acute pain from non-low back, musculoskeletal injuries. According to Dr. Arnot, these new guidelines will, “fundamentally change the way most Americans think about treating pain. Clinicians should treat patients with acute pain from non-low back, musculoskeletal injuries with topical nonsteroidal anti-inflammatory drugs (NSAIDS). A great example is the Salonpas Pain Relief Patch, which is applied directly to the site of pain.” For more information, visit Salonpas.us About Dr. Bob Arnot: Dr. Arnot is an Emmy award-winning broadcast journalist and author who was previously Chief Medical Correspondent for NBC and CBS News. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their.It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

October 28, 2020 12:00 PM Eastern Daylight Time

Video

GoGetTested Offers Free FDA-Approved COVID-19 Testing in Columbia, South Carolina

Go Get Tested

GoGetTested , the first end-to-end COVID-19 testing and results management solution in the country, today announced the availability of its FDA-approved, “gold-standard” PCR COVID-19 testing in Columbia, South Carolina. In a nationwide push to offer fast, easy and accessible COVID-19 testing for all, GoGetTested will open its Covid Response Operating System and mobile testing sites throughout the city. All tests are free for South Carolina residents, regardless of whether they are insured, since the state is covering the costs. Those without health insurance can also receive free testing through the CARES Act. “With a surge in new cases across the nation, city officials in Columbia are actively seeking ways to stay ahead of the curve, including new business safety measures and mask ordinances, in addition to more widespread and rapid testing,” said WellHealth CEO Ahmad Gaber, one of the founding partners of GoGetTested. “We’re offering the only turnkey solution that delivers a seamless and secure COVID-19 testing experience, from scheduling, check-in and results delivery to clinical interactions.” As of Wednesday, October 28, residents in South Carolina can now schedule a test in seconds, complete the test in minutes at one of the testing sites and have their results delivered via text or email within a couple of days. By using a unique mobile testing approach, GoGetTested has quickly expanded its geographical reach, especially in rural areas, and can swiftly deploy testing in COVID-19 hotspots. “In anticipation of the convergence of the seasonal flu and COVID-19 cases this fall and winter, we want to make it easier for South Carolinians to get tested--especially those who may have been exposed to the virus,” said Gaber. “We will also be deploying additional healthcare services once COVID-19 vaccines are available, as well as general symptoms checks and provider consults, to help keep our communities open and safe.” GoGetTested was launched as a semi-public, semi-private industry consortium with founding partners from precision primary care startup WellHealth, Silicon Valley-based healthcare fintech startup Wellpay among other private company partners. To date, they have delivered over 110,000 COVID-19 tests and have the ability to continue testing at a rate of tens of thousands per day. GoGetTested is currently serving residents in Texas, Florida and South Carolina, and will expand testing to Nevada, Arizona, Missouri and other states in the coming weeks. For more information on scheduling a test, visit www.gogettested.com . About GoGetTested GoGetTested is the first national, digitally enabled test scheduling to result management platform in the country. Its complete end-to-end COVID-19 testing experience will help keep the nationâs communities and economies open and safe. GoGetTested was founded as a unique public-private consortium of government, clinical, technology, lab, research and retail partners, including WellHealth and Wellpay, among other companies. Its Covid-19 response units ensure geographical reach to rural areas and fast activation in virus hotspots. Testing is free for anyone and provides the most complete, adaptive and secure testing services nationwide. Contact Details April White +1 323-216-8589 gogettested@trustrelations.agency Company Website https://www.gogettested.com/

October 28, 2020 08:08 AM Eastern Daylight Time

Aspira Women’s Health Addresses Clinical Disparities in Ovarian Cancer Risk Assessment with OVA1plus Across Racial Profiles

Aspira Women's Health Inc.

Contact Details Jaime Abrusci +1 646-599-8606 jabrusci@rxmedyn.com Company Website https://aspirawh.com/

October 28, 2020 08:00 AM Eastern Daylight Time

Video

SullivanCotter Releases Enhanced Patient Panel Management Capabilities for its Provider Performance Management Technology™

SullivanCotter

SullivanCotter, the nation’s leading independent consulting firm in the assessment and development of total rewards programs, workforce solutions, and technology and data products for the health care industry and not-for-profit sector, launches expanded patient panel management functionality in the latest update of its comprehensive Provider Performance Management Technology™ (PPMT). PPMT™ is an industry-first, cloud-based product that enables provider engagement through transparent performance-based compensation administration, reporting and analytical capabilities. As the focus on optimizing team-based care to achieve better patient outcomes intensifies, health care organizations require more effective strategies and resources for facilitating patient panel management. PPMT™ enables organizations to automate the assignment of patients to clinician panels through sophisticated client-defined rules. It then calculates a risk-adjusted panel size and applies compensation calculations for a group or individual based on an organization’s requirements – providing the flexibility to change patient attribution and/or panel compensation assignments as clinical teams evolve. PPMT™ allows for greater transparency into panel composition and serves as a single, centralized source of truth for clinician compensation. “Properly attributing patients to the correct clinician’s panel can require hours of administrative time each month. Combined with detailed analytics and powerful auditing and adjustment tools, the new panel management functionality streamlines this process to ensure more accurate attribution and support effective panel management programs,” said Shelly Slowiak, Director, Product Support, Provider Performance Management Technology™, SullivanCotter. Designed to address a spectrum of physician, leadership and other key stakeholder needs, PPMT™ combines years of health care compensation insight and expertise with an intuitive, automated technology platform to help drive clinician performance and support the transition from volume- to value-based care. It incorporates SullivanCotter’s industry-leading benchmarking data into three integrated modules, including Provider Performance Management, Provider Productivity Insights and Compensation Management Analytics. “We’re working hard to understand our clients’ changing needs and priorities and, as a result, will continue to refine our product roadmap and deliver the functionality they require to help navigate such a dynamic marketplace. This innovative new functionality will serve to strengthen our existing panel management capabilities, and is a welcome addition to PPMT™ as we strive to develop one of the industry’s most comprehensive, end-to-end technology products for managing clinical compensation and performance,” said David Schwietz, Chief Information Officer, SullivanCotter. For more information on the panel management functionality or our entire suite of Provider Performance Management Technology™ , visit www.sullivancotter.com/PPMT or contact us at 888.739.7039. About SullivanCotter SullivanCotter partners with health care and other not-for-profit organizations to understand what drives performance and improve outcomes through the development and implementation of integrated workforce strategies. Using our time-tested methodologies and industry-leading research and information, we provide data-driven insights and expertise to help organizations align business strategy and performance objectives – enabling our clients to deliver on their mission, vision and values. Contact Details Becky Lorentz +1 314-414-3719 beckylorentz@sullivancotter.com Company Website https://sullivancotter.com/

October 28, 2020 08:00 AM Eastern Daylight Time

Graphic novel: Disinformation and cyber warfare illustrated in Real Fake

Stockwood Strategy

Deepfakes, bots, and troll farms are just some of the emerging techniques for creating and spreading disinformation. Erly Stage Studios has today published Real Fake , the digital graphic novel, which sheds a light on the disruptive forces at work. This book is the first of the graphic novels that are a part of the Resilience Series commissioned by the US Cyber Infrastructure and Security Agency (CISA). Real Fake will inform and educate people on the dangers and risks associated with dis- and mis- information through fictional stories inspired by real-world events. In Real Fake, readers will meet the protagonist Rachel O'Sullivan, a gamer, patriot and member of Symous - a group fighting disinformation and foreign interference in elections as polling day approaches. Farid Haque, founder and CEO of Erly Stage Studios commented: “We’re delighted to have been commissioned by CISA to create a practical and engaging communication tool that highlights the existential threat of disinformation in the context of bad state actors. While the story is fictional many of the approaches shown are very much grounded in the reality of the technology we live with and are exposed to almost daily.” Real Fake provides a unique education for the reader about the world of Deepfakes and their history while helping the reader understand the need to exercise care when it comes to consuming news and information via social media platforms and online sources of information. In the story, racing against the clock a group of citizens set out to shine a spotlight on the source of disinformation. They find it’s coming from across their borders and from the unlikeliest of places set up as farms to perpetuate information that maliciously misleads and influences electoral outcomes. The protagonists of the story have access to unique resources and are able to prove who the sponsors of disinformation are via their puppet farms set up around the world to troll democracy in the land of the free. “Real Fake is the culmination of the wealth of experience that Clint Watts brings in cyber warfare and disinformation and our studio’s creative direction and storytelling style. We spent months researching the real life incidents and then wrapped them into a fictional story” added Farid Haque. The graphic novel is being made available by CISA to the general public online as a free resource ahead of the 2020 US Presidential election at the following URL: https://www.cisa.gov/cfi-resilience-series-graphic-novels . A subsequent title in the series will be released a few weeks afterwards titled Bug Bytes. Watch this space and log back into https://www. publishing.erlystagestudios.com to learn more. Contributing artists to Real Fake include: Annas Dar, Jose Niño Galenzoga, Patricia Beja, Mona Shan and Joel Santiago. Lettering and layouts by Annas Dar, Komal N. and Haroon M. Story by Clint Watts and Farid Haque, supported by the script writing team which includes Michael Gianfrancesco and Kabir Sabharwal. Edited by Tolly M. and Laila Khan. Special thanks to Randall Heather and Max Brooks. ENDS About Erly Stage Studios Erly Stage Studios is an indie publisher, headquartered out of London, United Kingdom, capturing iconic stories in serious graphic novels. We are an expert team of educators, storytellers, and artists working to create awareness about important topics using the graphic novel medium. The team loves shining a spotlight on stories that are yet to see the light of graphic novels. As an expert team of teachers, researchers and designers the team works with innovative organisations and policymakers around the world to deliver soft power through engaging and creative projects. Contact Details Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://publishing.erlystagestudios.com/

October 28, 2020 07:00 AM Eastern Daylight Time

Image

George Mason University wins grant for “return to work” pilot programs for antibody and diagnostic testing

Fairfax County Economic Development Authority

George Mason University’s College of Health and Human Services and College of Science have been awarded a $100,000 GO Virginia Economic Resilience and Recovery Grant to establish critical infrastructure to improve COVID-19 symptom monitoring and tracking, and diagnostics and facilitate a safe return to work. The initiative will simplify workplace monitoring for symptoms and testing for the COVID-19 virus and antibodies and will improve how contacts are traced when the virus is detected. Capabilities such as effective and easy-to-scale methods for diagnostic and antibody testing and contact tracing are key to a safe return. The interdisciplinary project brings together epidemiologists, nurse researchers, health informatics specialists, and laboratory scientists to create a holistic return to work program that can be scaled up. Dr. Amira Roess, an epidemiologist and professor in the Department of Global & Community Health , is leading the project, which includes integration of symptom, exposure, and behavioral data with regular testing following exposures. Roess brings extensive experience in outbreak and emergency preparedness and response. She advises public and private organizations, including K-12 schools, judicial systems, universities, and businesses on how to safely resume operations. Dr. Lance Liotta, professor in the School of Systems Biology and co-director and co-founder of Mason’s Center for Applied Proteomics and Molecular Medicine (CAPMM) is leading a team that developed a novel saliva-based antibody test, which is easier to use than other tests and has the potential for higher sensitivity and specificity than previous formats. “With breakthroughs in screening, surveillance, and testing, Mason faculty are leading efforts to fight COVID-19 in the region and around the country. The research happening here helps lay the groundwork for the economic recovery of Northern Virginia and the potential for developing commercially-available tests right here in the region,” said Dr. Aurali Dade, Mason’s interim vice president for research, innovation and economic impact. The pilot will focus on understanding the physical and mental health impact of COVID-19 on the workforce, especially among essential, front-line workers such as those in health care, first responder roles, education, and retail. The team plans to use the results to develop tailored stress management interventions and programs to enhance safe return to work for these populations. Leaders at the Fairfax County Economic Development Authority and Prince William Department of Economic Development voiced their support for the pilot initiative and the impact a widely available, non-invasive antibody test coupled with enhanced diagnostic testing can have on the region’s ability to resume key operations. Bringing a COVID-19 testing protocol to market in Northern Virginia could also have longer-term benefits to the region and its growing life sciences and information technology sectors. “This is an important effort to understand more about COVID-19 and its effects on the population, and I am delighted to see it moving forward,” said Victor Hoskins, president and CEO of the Fairfax County Economic Development Authority . “This effort also is the latest example of innovators in the Northern Virginia technology community collaborating to improve people’s lives, and we should be proud that this kind of discovery happens here.” "I'm so proud to call Mason one of Prince William County's own and I'm excited to see this study move forward," said Christina M. Winn, executive director of the Prince William County Department of Economic Development . "It's such an important step in building confidence in our community and preparing our region for safely getting back to work." The GO Virginia Economic Resilience and Recovery Grant Program was created by the Virginia Department of Housing and Community Development (DHCD) Growth and Opportunity for Virginia Board. George Mason University matched the grant with $50,000 in funding. "In creating the Economic Resilience and Recovery program, the GO Virginia State Board pivoted resources to focus on near term strategies to mitigate the economic impacts of the pandemic and this project is a perfect example of an innovative regional solution. This collaborative project leverages unique assets in Northern Virginia and we look forward to seeing the results of this pilot and its potential to inform reopening strategies," said Sara Dunnigan, deputy director, GO Virginia and Economic Development at DHCD. The Fairfax County Economic Development Authority promotes Fairfax County as a business and technology center. In addition to its headquarters in Tysons, Fairfax County’s largest business district, the FCEDA maintains business investment offices in six important global business centers: Bangalore/Mumbai, Berlin, London, Los Angeles, Seoul and Tel Aviv. Follow the FCEDA on Facebook , Instagram , LinkedIn , Twitter and YouTube . The Prince William County Department of Economic Development’s mission is “to improve the County’s economic base by encouraging new businesses to locate in Prince William County, retain existing businesses and encourage existing businesses to expand.” The Department works hard to create a pro-business, globally-competitive environment that generates new, high-quality, and sustainable job opportunities for our citizens and engages in a broad portfolio of services, partnerships, and strategic alliances to benefit the business community and stimulate the economy. The Fairfax County Economic Development Authority and the Prince William County Department of Economic Development are members of the Northern Virginia Economic Development Alliance . Other members of NOVA EDA are the Alexandria Economic Development Partnership, Arlington County, City of Fairfax, City of Falls Church, Fauquier County, Loudoun County, City of Manassas and City of Manassas Park. Contact Details ALAN FOGG +1 571-213-5065 afogg@fceda.org Company Website https://www.fairfaxcountyeda.org

October 27, 2020 11:07 AM Eastern Daylight Time

FABER DISTILLING ESTABLISHES FOUNDATION SUPPORTING VULNERABLE COMMUNITIES

The Faber Foundation

Earlier this year, Pennsylvania-based Faber Distilling Co . (Faber) shifted production of its high-quality vodkas, gin, and rum to the manufacture of hand sanitizer ( Faber Hand Sanitizer .) While many distillers have made similar adjustments, Faber scaled the production of its hand sanitizer to supply consumers as well as medical professionals and first responders when supplies were scarce. Continuing with its mission to put sanitizer and other personal protection equipment (PPE) into the hands of those who need it most, the company is announcing the launch of The Faber Foundation – a charitable organization. The mission of the Faber Foundation is to help combat the spread of COVID-19 by equipping those who need hand sanitizer and other PPE with these critical supplies – quickly and efficiently. “When the pandemic escalated in the United States, our founders rose to the challenge and converted a distillery into a hand sanitizer production facility. By producing millions of bottles and distributing nationwide, Faber Sanitizer helped fill the void during the sanitizer shortage of 2020. Now, our founders are turning their efforts to help those communities that are still struggling to obtain PPE,” explained Faber’s Director of National Accounts, Brenden Pakebusch. “More than 1,000,000 bottles of hand sanitizer and other PPE worth more than $2,000,000 is already slated for donation, and with greater cooperation, even more is possible.” The beneficiaries of Faber Foundation’s generosity include organizations, large and small, which work directly with the Federal Emergency Management Agency (FEMA) and the American Red Cross. Organizations that need sanitizer and PPE are encouraged to contact the Faber Foundation here: https://www.thefaberfoundation.com/inquiries As COVID-19 continues to disrupt public health and the economy, those wishing to support this cause are encouraged to donate here: https://www.thefaberfoundation.com/donate . “When Faber began manufacturing sanitizer, we responded to the immediate needs of so many organizations and individuals to obtain product. Although supplies have become more plentiful, challenges still remain in getting sanitizer into the hands of health professionals, first responders, and other essential workers who need it most,” Pakebusch continued. “The Faber Foundation is proud to meet these needs and welcomes the support of others wishing to participate.” The Faber Foundation ensures that donations are immediately deployed, getting essential supplies out in real time, with the cost of transportation and shipping also contributed. The Foundation does not assess any management or administrative fees, allowing nearly 100% of these donations to benefit nonprofit organizations and essential workers. “These are difficult times and helping ease anxieties by removing the obstacles of obtaining sanitizer and PPE to combat the spread of COVID-19 is essential,” said Pakebusch. “If you want to support something that will truly save lives and help to turn the tide of the pandemic, then the Faber Foundation is an efficient and effective organization that is already making a difference.” The Faber Foundation’s existing supply and access to hand sanitizer can reassure nonprofit organizations, school leaders, healthcare workers, and others on the front lines, that the hand sanitizer follows FDA guidelines, and will be available when they need it. Product is shipped directly in a variety of pack sizes as well as by the pallet load. To learn more about the Faber Foundation’s Hand Sanitizer and support global health, please visit https://www.thefaberfoundation.com . ### To schedule an interview with Faber’s Brenden Pakebusch please contact Dan Rene of kglobal at 202-329-8357 or daniel.rene@kglobal.com. Contact Details Dan Rene +1 202-329-8357 daniel.rene@kglobal.com Company Website https://fabersanitizer.com/

October 22, 2020 03:30 PM Eastern Daylight Time

Quidel Corporation Joins Global Lyme Alliance as Sponsor for the GLA 'Fight Lyme With Avril Lavigne and Friends' Virtual Concert Oct. 24

Quidel Corporation

As part of its commitment to help educate Americans on the perils of Lyme disease, Quidel Corporation announced today that it will be one of the sponsors of the inaugural Global Lyme Alliance (GLA) “#FightLyme With Avril Lavigne & Friends ” concert being held on Oct. 24. Quidel is the diagnostic health care manufacturer behind the industry’s most rapid and reliable in-office test for Lyme disease, the Sofia 2 Lyme FIA test. “The Global Lyme Alliance has been a passionate and important partner for Quidel in our fight against Lyme disease,” said Judi Tilghman, Ph.D., vice president of technology assessment at Quidel. "Over the years they have helped fund the most urgent and promising research in the field, while expanding education and awareness programs for the general public and physicians. We’re honored to be their partner for this wonderful upcoming event.” Being held in lieu of its annual gala, GLA will be presenting the inaugural #FightLyme With Avril & Friends virtual concert featuring Avril Lavigne, Rob Thomas, OneRepublic, Alessia Cara and host Wilmer Valderrama . The concert is designed to raise awareness and funds for GLA and The Avril Lavigne Foundation in support of their fight to conquer Lyme disease and other tick-borne diseases through research, education, awareness and patient services. Both Lavigne and Thomas have experienced Lyme disease on a personal level, and Lavigne is also a GLA board member who has been extremely vocal about the fight against Lyme disease. The Oct. 24 concert will begin at 8 p.m. Eastern Time. Tickets can be purchased and more information is available at https://tinyurl.com/y54dn89a . More information on the Global Lyme Alliance can be found at GLA.org. Lyme disease afflicts as many as 400,000 Americans every year and can lead to a number of serious, life-threatening problems if not caught early. Leading the way in Lyme disease testing is Quidel’s innovative Sofia® 2 Lyme FIA test. This test provides a patient as well as his or her physician with indicative results within minutes as opposed to days, which has historically been the norm. Performed in the privacy of a doctor’s office or local clinic, it is also the only test that can get results from a simple finger prick of blood. Given that the vast majority of patients tested are negative, not having to wait days for test results allows physicians and nurse practitioners to more rapidly treat those patients with positive results while more quickly pursuing other diagnosis and treatment for those who test negative. About Quidel Corporation Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic solutions at the point of care delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world. For more information about Quidel, visit quidel.com . # # # Contact Details Jim Yeager +1 424-644-0225 jim@breakwhitelight.com Company Website http://Quidel.com

October 22, 2020 08:00 AM Eastern Daylight Time

Cyvatar Named Finalist in Computing Security Excellence Awards 2020

Cyvatar

Cyvatar today announced that it has been chosen as a finalist for the Small and Medium Enterprise (SME) Security Solution Award in Computing’s 2020 Security Excellence Awards . Computing celebrates the achievements of the IT industry's leading security companies, solutions, products, and personalities that keep every other part of the industry operating. Award categories include product-and project-related recognition, organizational achievements, and accolades for outstanding individual success. Computing selected Cyvatar for its cybersecurity-as-a-service (CSaaS) solution for SMEs , an all-in-one subscription-based offering that builds bespoke solutions for customers who are not large enough to invest in in-house security teams, do not have the runway to experiment with multiple security tools as they scale, or cannot compete against larger firms for the scarce number of skilled resources available. By pairing skilled security experts with market-leading technologies across the security spectrum and pricing based on consumption, Cyvatar can deliver guaranteed business outcomes and demystify the complexities inherent in cyber defense. “Every organization is different, but most vendors don’t treat them that way,” said Cyvatar Founder Corey White . “We work side by side with our customers--not across the table from them--to break down barriers that impede a strong protective posture and create a flexible, affordable environment that fosters positive security experiences. No other services provider matches the quality of our technology partners, the deep skills of our security experts, or the business outcomes we guarantee.” Cyvatar believes in the democratization of cybersecurity, ensuring that protection from breaches is accessible and affordable to SMEs--not just to enterprises with deep pockets and dedicated security teams. It also believes in teaching and training SMEs to get the most from every dollar they spend on cybersecurity without the shrouded black-box approach that requires vendor-specific support to operationalize. And Cyvatar lives its values. Its promise to SMEs states that it will never tell customers to buy unnecessary products or hire unneeded resources; will ensure customers make the best security investments for functionality and value; and will consistently deliver maintainable and sustainable business, compliance, and technology outcomes. What security challenges are you trying to solve? What barriers do you face? Visit https://start.cyvatar.ai/ to explore the ways Cyvatar can help. About Cyvatar Cyvatar.ai is a transformative cybersecurity company that operates at the intersection of our customers and technology to define what a cybersecurity solution should be: guaranteed business outcomes that are measurable. We break down barriers to create positive experiences for passionate companies globally. Cyvatar is headquartered in Irvine, California. Learn more at https://cyvatar.ai/ and follow us on LinkedIn and Twitter . Contact Details KC Higgins +1 303-434-8163 kc@cyvatar.ai Company Website https://cyvatar.ai/

October 20, 2020 08:34 AM Eastern Daylight Time

1 ... 286 287 288 289 290 ... 300